Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 720.00
-16.10 (-2.19%)
Jun 1, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 141.53 billion as of June 1, 2026. Its market cap has decreased by -20.07% in one year.
Market Cap
141.53B
Enterprise Value
153.74B
Revenue
73.45B
Ranking
n/a
PE Ratio
20.97
Stock Price
720.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 141.53B, an increase of 1,472.22%. That is a compound annual growth rate of 20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 144.69B | -13.01% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 327.10B |
| Wockhardt | 287.77B |
| Piramal Pharma | 229.44B |
| Eris Lifesciences | 187.18B |
| NATCO Pharma | 181.96B |
| Cohance Lifesciences | 164.03B |
| Alivus Life Sciences | 131.36B |
| Strides Pharma Science | 106.40B |